Cytokinetics Stock News & Updates

[WKN: A1W1KK | Symbol: CYTK]

Cytokinetics: H.C. Wainwright Sees 121% Price Potential Following Presentation of Primary Results from the MAPLE-HCM Phase 3 Study

Cytokinetics (CYTK) is a specialist in cardiovascular biopharmaceuticals, and the company recently presented...

Cytokinetics - The Biotech Company Sees a Share Price Jump after Positive Study Results for Aficamten!

Business drivers: Cytokinetics (CYTK) specializes in developing new methods for the treatment of muscular...

5 Rising Biopharma Stocks with over 50% Annual Growth Potential

Dear readers, Last week, I introduced five biopharma stocks that have taken off in recent weeks. It...

Cytokinetics Revolutionizes the Treatment of Heart Muscle Diseases – Aficamten Is a $3.4 Billion Opportunity!

Cytokinetics (CYTK) specializes in developing innovative therapies for treating heart muscle diseases...

Analysts' Top 5 Price Targets of September 2, 2025

Cytokinetics [US23282W6057] Citigroup reaffirms Buy rating and raises the price target from $77...

Stocks in Action USA: Scholastic (SCHL), Cytokinetics (CYTK), Alnylam (ALNY)

Scholastic (SCHL) stock surges: Largest price increase since July 2022 = small hope for a rebound! ...

  • 1